摘要: The major cause of death from the most common type lung cancer, NSCLC,[2][1] is attributable to metastasis and responsible for more than 155,000 deaths annually in United States alone. prognosis choice therapy patients with cancer currently based on clinical stage
aacrjournals.org参考文章(15)
David J. McConkey, Roy S. Herbst, Hiroki Kuniyasu, Corazon D. Bucana, Hisashi Shinohara, Darren W. Davis, Lee M. Ellis, Isaiah J. Fidler, Seiji Yano, Expression of vascular endothelial growth factor is necessary but not sufficient for production and growth of brain metastasis. Cancer Research. ,vol. 60, pp. 4959- 4967 ,(2000)
Francesco Pezzella, Ugo Pastorino, Elda Tagliabue, Salvatore Andreola, Gabriella Sozzi, Giampietro Gasparini, Sylvie Menard, Kevin C Gatter, Adrian L Harris, Steve Fox, Marc Buyse, Silvana Pilotti, Marco Pierotti, Franco Rilke, None, Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis American Journal of Pathology. ,vol. 151, pp. 1417- 1423 ,(1997)
Corazon D. Bucana, Eiichi Tahara, Yasuhiko Kitadai, Karen R. Cleary, Graham F. Greene, Graham F. Greene, Susan L. Tucker, Lee M. Ellis, Isaiah J. Fidler, Yutaka Takahashi, Multiparametric in situ mRNA hybridization analysis to predict disease recurrence in patients with colon carcinoma. American Journal of Pathology. ,vol. 149, pp. 1541- 1551 ,(1996)
G Fontanini, L Boldrini, S Chinè, F Pisaturo, F Basolo, A Calcinai, M Lucchi, A Mussi, C A Angeletti, G Bevilacqua, Expression of vascular endothelial growth factor mRNA in non-small-cell lung carcinomas. British Journal of Cancer. ,vol. 79, pp. 363- 369 ,(1999) , 10.1038/SJ.BJC.6690058
M Volm, J Mattern, R Koomagi, Expression of platelet-derived endothelial cell growth factor in non-small cell lung carcinomas: relationship to various biological factors. International Journal of Oncology. ,vol. 13, pp. 975- 979 ,(1998) , 10.3892/IJO.13.5.975
ALEXANDRA GIATROMANOLAKI, MICHAEL KOUKOURAKIS, KEN O'BYRNE, STEPHEN FOX, RUTH WHITEHOUSE, DENIS C. TALBOT, ADRIAN L. HARRIS, KEVIN C. GATTER, PROGNOSTIC VALUE OF ANGIOGENESIS IN OPERABLE NON-SMALL CELL LUNG CANCER The Journal of Pathology. ,vol. 179, pp. 80- 88 ,(1996) , 10.1002/(SICI)1096-9896(199605)179:1<80::AID-PATH547>3.0.CO;2-X
Paolo Macchiarini, Gabriella Fontanini, Elisabeth Dulmet, Vincent De Montpreville, Alain R. Chapelier, Jacques Cerrina, François Le Roy Ladurie, Philippe G. Dartevelle, Angiogenesis: An indicator of metastasis in non-small cell lung cancer invading the thoracic inlet The Annals of Thoracic Surgery. ,vol. 57, pp. 1534- 1539 ,(1994) , 10.1016/0003-4975(94)90117-1
Clifton F. Mountain, John M. Lukeman, Samuel P. Hammar, Dean W. Chamberlain, Walter F. Coulson, David L. Page, Thomas A. Victor, Louis H. Weiland, , Lung cancer classification: the relationship of disease extent and cell type to survival in a clinical trials population. Journal of Surgical Oncology. ,vol. 35, pp. 147- 156 ,(1987) , 10.1002/JSO.2930350302
G. Fontanini, S. Vignati, F. Basolo, G. Bevilacqua, M. Lucchi, A. Mussi, C. A. Angeletti, F. Ciardiello, M. De Laurentiis, S. De Placido, Angiogenesis as a Prognostic Indicator of Survival in Non-Small-Cell Lung Carcinoma: a Prospective Study Journal of the National Cancer Institute. ,vol. 89, pp. 881- 886 ,(1997) , 10.1093/JNCI/89.12.881
K. O'byrne, A. Giatromanolaki, F. Pezzella, P. A. E. Scott, H. Turley, K. C. Gatter, V. Georgoulias, A. L. Harris, S. Kakolyris, M. I. Koukourakis, Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer. Clinical Cancer Research. ,vol. 4, pp. 3017- 3024 ,(1998)